Jose I Nunez

Cardiology🫀 @MonteHeart| 🇻🇪

[Jose I Nunez @JNunezMD]

Published online today! Our study on contemporary use of VA-ECMO in acute myocarditis finally out in @CircHF ! Survival is favored in this subset of patients w/ ~2/3 surviving to discharge. Take a look! Thanks to @ReshadGaranMD @WilsonGrandinMD @ELSOOrg
https://t.co/my0kMB9w8E

[Louis Verreault-Julien, MD, MPH @lvjulien_md]

Excited to announce that Montefiore will now have its CHIP/CTO fellowship starting in 2027. Apply now to one of the busiest complex PCI programs in the Northeast!

@MontefioreNYC @MonteHeart @azeemlatib @SCAI

[Jose I Nunez @JNunezMD]

@AndreaScotti21 @leoneppmd @m_assafin @CardioMDPhD @jtorrado_arrosa @azeemlatib @MonteHeart

[Jose I Nunez @JNunezMD]

🫀 New from the Bronx-Valve Registry:

📊 ~12% of patients with severe VHD had multivalvular involvement. Mitral-tricuspid was the most common combination (68.4%), followed by aortic-mitral and aortic-tricuspid. Now available in AJC

https://t.co/BgNS28zQIX

[The New York Times @nytimes]

From @TheAthletic: For the first time in the 20-year history of the World Baseball Classic, Venezuela can call itself the champions of the baseball world. They beat the greatest collection of American baseball players ever assembled. https://t.co/eMNpC4PUYM

[Davide Capodanno @DFCapodanno]

Finally published: the COBRRA trial, the first randomized head-to-head comparison of major DOACs — something the companies would never have done themselves, as a direct confrontation goes beyond their commercial interests. This was driven by independent investigators. The results somewhat support the idea of apixaban being the “safer” DOAC. That said, the list of study limitations is long, and for me, labeling something as “safe” is not enough — after all, even placebo is “safe” when it comes to bleeding. https://t.co/eYehndGzvB

[Ivan C Aivasovsky MD @IAivasovsky]

https://t.co/UEBHqhTC7A

[Ivan C Aivasovsky MD @IAivasovsky]

Two of our projects are now up at #CTO2026!

- Impella-Assisted PCI Using Dual vs Single Access: Increased Bleeding Risk With Dual Access
- When Nothing Crosses: RPDA Stingray ADR for a Distal Recanalized RCA CTO

[Evandro Martins F. MD @evandrofilhobr]

The favorable SVG PCI results in PROCTOR likely reflect:
✅ Careful selection of viable, non-degenerated grafts
✅ Shorter, softer, focal lesions amenable to DES and EPD use
✅ Avoidance of the truly high-risk “old crumbly SVG” subset

So, it’s not that SVG PCI suddenly became “better” in general; it’s that in the right graft, with modern tools and technique, it can outperform PCI of a hostile native vessel in the short term.

[Louis Verreault-Julien, MD, MPH @lvjulien_md]

Happy to share our latest publication in JACC Case Reports highlighting some important concepts of coronary perforation management.

@azeemlatib @JNunezMD @WaqaHanif @ffr81 @RinfretStephane @andrea_mignatti

https://t.co/yeH9AAwCgI

[Ursula von der Leyen @vonderleyen]

Felicitaciones, @MariaCorinaYa, por recibir el Premio Nobel de la Paz.

This award honours not only your courage and conviction.

But every voice that refuses to be silenced. In Venezuela and across the world.

It sends a powerful message.

The spirit of freedom cannot be jailed.

The thirst for democracy always prevails.

Dear María, the fight continues.

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The Norwegian Nobel Committee has decided to award the 2025 #NobelPeacePrize to Maria Corina Machado for her tireless work promoting democratic rights for the people of Venezuela and for her struggle to achieve a just and peaceful transition from dictatorship to democracy.

#NobelPrize

[NEJM @NEJM]

Presented at #ESCCongress:

In older adults with impaired physical performance after MI, multidomain rehabilitation reduced cardiovascular death or unplanned hospitalization at 1 year, with no serious adverse effects. Full PIpELINe trial results: https://t.co/HLDrHuzGrP

@escardio

[Jake Scott, MD @jakescottMD]

RFK Jr. went on national TV and spouted egregious, dangerous falsehoods about vaccines. As a parent and infectious diseases doctor, I couldn't stay silent. @FoxNews might not fact-check him, but I will. I've reviewed the trials. I've catalogued them. I have receipts. 🧵

[Caracas Chronicles @CaracasChron]

🫓 How has the gaze over Venezuelans changed in one year.

One year ago we were an example of bravery and democratic values.

Today we are parias.

We didn’t change.

[Dhruv Kazi @kardiologykazi]

The proposed “Most Favored Nation Drug Pricing” (MFN-DP) plan is the most ambitious plan yet to rein in US drug spending.

How did we get here? How would MFN-DP work? What are the expected short, intermediate, & long-term consequences?

Here are my top 10 takeaways (so far)-
1/

[JACC Journals @JACCJournals]

New from #ACC25: Dr. Nuccia Morici & colleagues report the results of ALTSHOCK-2, finding that early implantation of IABP does *not* reduce 60-day mortality in #heartfailure-related cardiogenic shock

#JACC 🧵 (1/4)

[Jose I Nunez @JNunezMD]

@cris7ian This 🧵 is 🔥
My dude spitting facts

[Laura_Weffer @Laura_Weffer]

Durante 10 años cubrí a Chávez, mañana, tarde y noche. Escuchaba sus discursos y escribía sobre sus políticas.
Hoy, desde Estados Unidos, me parece estar reviviéndolo todo de nuevo. Cada decisión, cada palabra, cada amenaza
Ya está historia me la sé y no me gusta.

[Jose I Nunez @JNunezMD]

Special thanks to mentors @MonteHeart @UlrichJordeMD Daniel Sims & Omar Saeed

[Jose I Nunez @JNunezMD]

Inflammation plays a critical role in VA-ECMO for cardiogenic shock. Our study out in @asaiojournal shows that a persistent 📈in neutrophil-to-lymphocyte ratio within 24-48 h post ECMO is linked to significantly higher mortality. Read here: https://t.co/cN1LSVROpL